Table 1

Results of histomorphometrical analysis of effects of the treatments on LuCaP 23.1 and bone


BV/TV (%)
TUV/TV (%)
TB.TH. (μM)
TB. N. (MM-1)
TB.SP. (μM)
OS.S./BS (%)
OS.TH. (μM)
OB.PM./BPM. (%)
N.OC./BS (%)

Control
23.09 ± 9.34
30.62 ± 5.75
94.89 ± 31.75
6.06 ± 1.41
76.87 ± 20.90
7.24 ± 1.82
4.57 ± 0.29
15.97 ± 5.08
1.91 ± 0.35
ZOL
36.51 ± 7.86
17.68 ± 6.79a
145.7 ± 31.64
5.08 ± 0.53
52.29 ± 13.51
3.96 ± 1.87
5.27 ± 0.45
8.46 ± 1.42a
0.83 ± 0.46a
DOC
29.46 ± 8.56
28.29 ± 11.18
81.53 ± 20.45
5.61 ± 0.90
100.6 ± 24.88
6.73 ± 1.84
5.21 ± 0.36
14.17 ± 4.36
1.19 ± 0.61
ZOL + DOC
40.38 ± 8.73a
11.13 ± 3.41a,b
118.5 ± 25.56
5.59 ± 0.51
61.48 ± 21.83
4.77 ± 1.01
4.98 ± 0.40
11.92 ± 5.90
0.77 ± 0.42a

Tumored tibiae were harvested after seven weeks of treatment and embedded in methacrylate. Analysis was performed on Goldner-stained longitudinal sections of tibiae (n = 5 per group).

Results are presented as a mean ± SD.

a p < 0.5 vs. control group

b p = 0.11 group 2 vs. group 4

Brubaker et al. BMC Cancer 2006 6:15   doi:10.1186/1471-2407-6-15